Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 5, 2015, Pages 960-969

  Wang, Lin ^a   Xu, Yongde ^a   Li, Huixi ^a   Lei, Hongen ^a   Guan, Ruili ^a   Gao, Zhezhu ^a   Xin, Zhongcheng ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Diabetes mellitus; Erectile dysfunction; Icariside II; Metabolic memory

Indexed keywords

ANTIOXIDANT; HEMOGLOBIN A1C; ICARISIDE II; INSULIN; MALONALDEHYDE; NEURONAL NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIDIABETIC AGENT; BAOHUOSIDE I; FLAVONOID; HERBACEOUS AGENT; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MEAN ARTERIAL PRESSURE; NICK END LABELING; NONHUMAN; PENIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEXUAL FUNCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; DRUG POTENTIATION; ERECTILE DYSFUNCTION; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PENIS ERECTION; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

RATTUS;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; ERECTILE DYSFUNCTION; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PENILE ERECTION; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 84928381395     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12480     Document Type: Article

References (23)

1. Castro RP, Hernandez PC, Casilda RR, et al. Epidemiology of erectile dysfunction risk factors. Arch Esp Urol. 2010; 63: 637-9.
2. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999; 84: 50-6.
3. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005; 47: 80-5.
4. Thorve VS, Kshirsagar AD, Vyawahare NS, et al. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications. 2011; 25: 129-36.
5. Cheitlin MD. Erectile dysfunction: the earliest sign of generalized vascular disease? J Am Coll Cardiol. 2004; 43: 185-6.
6. Dogra G, Rich L, Stanton K, et al. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia. 2001; 44: 593-601.
7. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care. 2003; 26: 1589-96.
8. Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003; 52: 818-23.
9. Lander HM, Tauras JM, Ogiste JS, et al. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem. 1997; 272: 17810-4.
10. Zhou F, Xin H, Liu T, et al. Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes. J Androl. 2012; 33: 832-44.
11. Usta MF, Kendirci M, Gur S, et al. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. J Sex Med. 2006; 3: 242-50.
12. Choi WS, Park K, Paick JS, et al. Time-dependent changes of erectile function in diabetic rats: role of systemic endothelial dysfunction. World J Mens Health. 2012; 30: 114-22.
13. Cho SY, Chai JS, Lee SH, et al. Investigation of the effects of the level of glycemic control on erectile function and pathophysiological mechanisms in diabetic rats. J Sex Med. 2012; 9: 1550-8.
14. Yuan YV, Kitts DD, Godin DV. Heart and red blood cell antioxidant status and plasma lipid levels in the spontaneously hypertensive and normotensive Wistar Kyoto rat. Can J Physiol Pharmacol. 1996; 74: 290-7.
15. Kim SY, Kim JW, Ko YS, et al. Changes in lipid peroxidation and antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer. Nutr Cancer. 2003; 47: 126-30.
16. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-72.
17. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360: 129-39.
18. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353: 2643-53.
19. Tanaka N, Yonekura H, Yamagishi S, et al. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem. 2000; 275: 25781-90.
20. Wei Q, Ren X, Jiang Y, et al. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord. 2013; 13: 13-23.
21. Silva FH, Monica FZ, Bau FR, et al. Superoxide anion production by NADPH oxidase plays a major role in erectile dysfunction in middle-aged rats: prevention by antioxidant therapy. J Sex Med. 2013; 10: 960-71.
22. Park JS, Park HY, Rho HS, et al. Statistically designed enzymatic hydrolysis for optimized production of icariside II as a novel melanogenesis inhibitor. J Microbiol Biotechnol. 2008; 18: 110-7.
23. Liu ZQ. Icariin: a special antioxidant to protect linoleic acid against free-radical-induced peroxidation in micelles. J Phys Chem A. 2006; 110: 6372-8.